Business Trends– category –
-
CRISPR Gene Editing Advances in 2026: Accumulation of Clinical Data and Evolving Regulatory Framework for Rare Diseases, Cancer, and Autoimmune Disorders
Industry report / Analysis USA Overview The CRISPR gene editing landscape in 2026 shows significant progress across rare diseases, hematologic and solid cancers, and autoimmune disorders. Clinical programs are generating crucial data, wh... -
Beam Therapeutics Receives U.S. FDA IND Clearance for BEAM-304, a Base Editing Therapy for Phenylketonuria (PKU)
Beam Therapeutics USA Overview Beam Therapeutics announced U.S. FDA Investigational New Drug (IND) clearance for BEAM-304, its investigational base editing therapy for Phenylketonuria (PKU). This milestone paves the way for human clinica... -
CRISPR Therapeutics Stock Volatility Driven by CASGEVY Commercialization and CTX112 Clinical Progress
Investing.com USA Overview CRISPR Therapeutics has experienced significant stock volatility due to market reactions to the commercialization of its approved CRISPR gene therapy, CASGEVY, and clinical developments for its off-the-shelf CA... -
Microsoft Unveils Enhanced AI Agent Capabilities for Dynamics 365, Boosting Productivity in Customer Service, Sales, and Marketing
Microsoft Official Blog USA Overview Microsoft has announced the introduction of significantly enhanced AI agent capabilities for its integrated business application suite, Dynamics 365. These new features will provide advanced automatio... -
Biologics CDMO BioManuTech Expands Facilities with AI-Driven Process Optimization, Boosting Efficiency and Quality of Complex Biopharmaceutical Manufacturing
Endpoints News USA Overview Biologics CDMO BioManuTech has announced a major facility expansion, integrating AI-driven manufacturing process optimization technology. This strategic investment is expected to dramatically enhance the produ... -
NVIDIA Partners with Middle Eastern Sovereign Funds to Build “Sovereign AI Cloud” Infrastructure, Prioritizing Data Sovereignty and AI Development
GlobeNewswire USA Overview NVIDIA has announced a strategic partnership with multiple Middle Eastern sovereign wealth funds and leading technology firms to establish a "Sovereign AI Cloud" infrastructure within the region. This initiativ... -
Pharmaceutical Giant PharmaCorp Partners with AI Robotics Firm RoboTech for Full Automation and Optimization of Drug Manufacturing
BioPharma Dive USA Overview Pharmaceutical giant PharmaCorp has announced a strategic partnership with AI robotics firm RoboTech to comprehensively automate and optimize its drug manufacturing processes. This collaboration aims to signif... -
AI-Driven Drug Discovery Platform StartupX Secures $50M Series B Funding, Aiming to Advance Pipeline to Clinical Trials
TechCrunch USA Overview StartupX, an AI-powered drug discovery platform provider, has successfully closed a $50 million Series B funding round. The company leverages advanced AI to accelerate target identification and lead compound optim... -
AI Drug Discovery Investment Surges to $10 Billion in 2026 with Eli Lilly Partnerships and Over 173 Clinical Programs, Highlighting Isomorphic Labs
MarketWise USA Overview Investment in AI drug discovery is booming in 2026, following Anthropic's CEO's prediction of a biotech renaissance, with AI and ML-related biopharma deals already nearing $10 billion. Key drivers include Eli Lill... -
Crunchbase Data Reveals US AI Startup Funding to Dominate Globally with $319 Billion by 2026, Widening Gap with Non-US Counterparts
Crunchbase USA Overview According to the latest Crunchbase data, AI startup funding is overwhelmingly concentrated in the US, projected to reach $319 billion by 2026. This starkly contrasts with the $45 billion raised by non-US startups,...
